NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyIllumina NovaSeq X Sequencing System
OD - NIH Office of the Director
About This Grant
Project Summary This grant application requests funds to acquire an Illumina NovaSeq X Sequencing System to support teams of well-funded biomedical researchers who are experienced in high throughout sequencing approach to conduct genomic analysis at the University of Texas Health at San Antonio (UTHSA). This instrument will be housed in the Genome Sequencing Facility (GSF) at the Greehey Children’s Cancer Research Institute (GCCRI), a campus-wide shared core facility operated by a team of well-trained and experienced staff and bioinformaticians specializing in sequencing and genomics technologies. Since its inception in 2011, the GSF, with a variety of high-throughput sequencing and genomic instruments, has become a critical component for genomic research and collaborations within UTHSA and across San Antonio region. Currently, high throughput sequencing is conducted on one Illumina NovaSeq 6000 and one NextSeq 2000 at GSF, and there are no other accessible NGS platforms within UTHSA or the surrounding San Antonio institutions. A wide array of basic, translational, clinical, and genomics studies at UTHSA depend on reliable access to a high-capacity, cost-effective sequencing platform supported by integrated bioinformatics analysis. The requested NovaSeq X Sequencing System will meet these requirements, thus enabling the GSF to provide cost effective, high-quality sequencing data to support NIH-funded biomedical research, benefiting 15 Major Users and 21 Other Users whose projects are in areas such as cancer, aging, pain management, immunology, diabetes, infectious disease, and neurodegenerative diseases, as outlined in this proposal. Our history and future planning demonstrate UTHSA’s strong commitment to advancing genomics research, fully supporting this grant application by providing the necessary resources for GSF's operation. Additionally, the new NovaSeq X System will enhance training opportunities for pre- and post-doctoral fellows, physicians, and young scientists, fostering excellence in genomics research and bioinformatics innovations at UTHSA and South Texas region. Thus, acquiring an Illumina NovaSeq X Sequencing System will significantly enhance the institution’s sequencing capacity, accelerate NIH-funded investigations, strengthen collaborative research, and contribute to improving health outcomes—particularly for the predominantly Hispanic population in South Texas.
Grant Summary
Illumina NovaSeq X Sequencing System is a OD - NIH Office of the Director grant providing up to $750K for university, nonprofit, healthcare org. Applications are due 2027-05-14 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $750K
2027-05-14
- 1Confirm your organization is eligible for Illumina NovaSeq X Sequencing System from OD - NIH Office of the Director, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to OD - NIH Office of the Director before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against OD - NIH Office of the Director's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Illumina NovaSeq X Sequencing System: Frequently Asked Questions
Who is eligible for the Illumina NovaSeq X Sequencing System?
Illumina NovaSeq X Sequencing System is offered by OD - NIH Office of the Director and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Illumina NovaSeq X Sequencing System provide?
Illumina NovaSeq X Sequencing System provides up to $750K per award from OD - NIH Office of the Director. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Illumina NovaSeq X Sequencing System deadline?
Applications for Illumina NovaSeq X Sequencing System are due 2027-05-14 (open). Because deadlines can change, verify the date with the funder, OD - NIH Office of the Director, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Illumina NovaSeq X Sequencing System?
To apply for Illumina NovaSeq X Sequencing System, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from OD - NIH Office of the Director.